AVO announces further delays to LIGHT system

By
Maria Davies
-
Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has attributed delays to the roll-out of its next generation proton beam therapy system LIGHT to unexpected additional requests from regulators. The…

You must be a HM Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR